P27 Rezafungin treatment of candidaemia and invasive candidiasis: outcomes stratified by baseline renal function—analysis of the Phase 2 + Phase 3 trials

BACKGROUND: Rezafungin (RZF) once weekly (QWk) is a next-generation echinocandin in development for treatment of candidaemia and invasive candidiasis (IC) and prevention of invasive fungal disease caused by Candida, Aspergillus, and Pneumocystis spp. in BMT. RZF QWk was compared with caspofungin (CA...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandison, Taylor, Vazquez, Jose A, Honore, Patrick M, Soriano, Alex, Horcajada, Juan P, Slavin, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266181/
http://dx.doi.org/10.1093/jacamr/dlad066.031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266181/
http://dx.doi.org/10.1093/jacamr/dlad066.031

Ejemplares similares